Basic Ordering Agreement 36C24219G0026
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a single-award Basic Ordering Agreement by Veterans Integrated Service Network 2 on November 22, 2016, with an ultimate completion date of May 31, 2022, and a ceiling value of $629,125.00. This agreement establishes a local consignment arrangement for the New York Harbor Healthcare System, with the contract structure supporting on-demand procurement of advanced cardiovascular medical devices. The BOA encompasses...
- The Basic Ordering Agreement is a single award contract with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The agreement facilitates consignment of Abbott stents, with a potential value of $363,355. Abbott Laboratories, through its division Abbott Vascular Inc., is the prime contractor. The contract provides for consignment of various cardiovascular stents to support treatment of veterans. As the parent company of Abbott Vascular, Abbott...
- The Basic Ordering Agreement (BOA) award, contract number 36C24219G0028, is a single-award indefinite delivery vehicle (IDV) issued by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. This $63,895 BOA, with a period of performance running through June 30, 2024, provides for the supply of ARMADA and OMNILINK cardiovascular surgical implants on a consignment basis to VA medical facilities. As a leading global healthcare company,...
- Veterans Integrated Service Network 1 awarded a Blanket Purchase Agreement to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on January 15, 2023, with a ceiling of one dollar and performance extending through July 14, 2030. This single-award BPA was established under Executive Order 14398 and carries no set-aside designation. The agreement supports cardiovascular medical device procurement and related services for VA healthcare operations. Abbott Vascular supplies advanced...
- The federal contract IDV is a Basic Ordering Agreement (BOA) awarded by the Department of Veterans Affairs (VA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division. The contract, valued at $0.00, allows the VA to issue task orders for the provision of vascular stents on a consignment basis to the Syracuse VA Medical Center. The BOA has an ultimate completion date of March 31, 2024. As a global healthcare company, Abbott Laboratories has established a strong presence in federal...
- The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Abbott Laboratories, with Abbott Vascular Inc. as the division responsible for delivery. The BPA has a potential value of $240,000 and a period of performance through June 30, 2023 for the procurement of stents from Abbott Laboratories. The BPA establishes consignment terms for stents to be provided by Abbott Laboratories on an...
- Abbott Laboratories has been awarded a single-award blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The agreement establishes terms and conditions for the delivery of stents to the Atlanta Veterans Affairs Medical Center on a consignment basis, with a potential value of $240,000 and a period of performance through December 31, 2022. As the sole awardee, Abbott Vascular Inc. will provide stents to the Atlanta...
- The Blanket Purchase Agreement was awarded as a single award by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to Abbott Laboratories, Division Abbott Vascular Inc. to provide Abbott cardiovascular stents on a consignment basis. The potential value of the agreement is $270,270 for the base period ending December 31, 2023. The agreement facilitates the delivery of Abbott's cardiovascular stents to various Veterans Affairs medical centers...
- Abbott Laboratories has been awarded a single-award blanket purchase agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. The agreement establishes terms and conditions for the delivery of stents to the Augusta VA Medical Center on a consignment basis, with a potential value of $240,000 and a period of performance through December 31, 2022. As the sole awardee, Abbott Vascular Inc. will provide stents to the Augusta VAMC for use in...
- The Department of Veterans Affairs awarded an indefinite-delivery contract to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, with a ceiling of $247,406,515.13 on December 11, 2023, designated as a single-award vehicle with no set-aside category. Place of performance spans multiple Veterans Integrated Service Networks and locations including Santa Clara, California; North Chicago, Illinois; Cleveland, Ohio; and Portland, Oregon, as well as subordinate VA medical centers...
This Basic Ordering Agreement (BOA) was awarded to Abbott Laboratories Inc.'s Abbott Vascular Inc. division by Veterans Integrated Service Network 2 (VISN 2), a civilian federal healthcare agency within the U.S. Department of Veterans Affairs, on April 12, 2019. The contract, which extended through December 30, 2022, established a procurement vehicle for cardiac and vascular stents to support cardiovascular care delivery across the Veterans Integrated Service Network 2 healthcare system. Abbott Vascular Inc., a subsidiary of Abbott Laboratories, is a specialized manufacturer of advanced cardiovascular medical technologies with extensive experience as a strategic supplier to Department of Veterans Affairs facilities, the Defense Logistics Agency, and the Department of Defense. As a single-award, non-set-aside contract, this BOA reflected Abbott's competitive positioning and established capability in providing critical cardiovascular implantable devices to federal healthcare systems. The contract structure allowed for flexible procurement of stent products on an as-needed basis through task orders, enabling VISN 2 facilities to address patient care requirements while maintaining cost control through an established contractual relationship. The Abbott Vascular Inc. portfolio delivered under this BOA and related Veterans Integrated Service Network contracts encompasses a comprehensive range of cardiovascular implantable devices and support services. Beyond the stents specified in this agreement, Abbott's federal contracting demonstrates delivery of transcatheter prosthetic surgical heart valves (Epic Plus Mitral, Regent Aortic, and Masters series), left ventricular assist device support and maintenance services, and integrated procedural packages including technical support and on-site expertise. Abbott's federal cardiovascular contracting demonstrates consistent execution through firm fixed-price arrangements and consignment inventory models, with the company maintaining parallel indefinite delivery contracts across multiple Veterans Integrated Service Networks and with the Defense Logistics Agency valued up to $117.1 million. This single-award BOA represented one element of Abbott's broader federal healthcare supply strategy, positioning the company as an essential provider of critical cardiac and vascular technologies essential for supporting complex surgical procedures and improving veteran patient outcomes within the Department of Veterans Affairs healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 5/5/21 | |
| P00002 | Other Administrative Action | $0 | 4/13/20 | |
| P00001 | Other Administrative Action | $0 | 10/10/19 | |
| P00004 | Other Administrative Action | $0 | 4/11/19 | |
| Not listed | Not listed | $0 | 4/9/19 |